author-photo

Raymond Rynberg

Johnson & Johnson Pharmaceutical Research and Development

11

Papers

177

Citations

Citation Trend

Filter By

Papers (8) Sort By

Journal Conference Others

The SAR of brain penetration for a series of heteroaryl urea FAAH inhibitors.

2016 Bioorganic & Medicinal Chemistry Letters
Show All
- Source
- Cite
- Save
Citations (7)
Preclinical Characterization of the FAAH Inhibitor JNJ-42165279

2015 ACS Medicinal Chemistry Letters
Show All
- Source
- Cite
- Save
Citations (35)
Pyrazole-based arylalkyne cathepsin S inhibitors. Part III: modification of P4 region.

2013 Bioorganic & Medicinal Chemistry Letters
Show All
- Source
- Cite
- Save
Citations (10)
Aryl Piperazinyl Ureas as Inhibitors of Fatty Acid Amide Hydrolase (FAAH) in Rat, Dog, and Primate

2012 ACS Medicinal Chemistry Letters
Show All
- Source
- Cite
- Save
Citations (25)
Practical Synthesis of a Cathepsin S Inhibitor: Route Identification, Purification Strategies, and Serendipitous Discovery of a Crystalline Salt Form

2010 Journal of Organic Chemistry
Show All
- Source
- Cite
- Save
Citations (10)
1,2-diamino-ethane-substituted-6,7,8,9-tetrahydro-5H-pyrimido[4,5-d]azepines as TRPV1 antagonists with improved properties.

2010 Bioorganic & Medicinal Chemistry Letters
Show All
- Source
- Cite
- Save
Citations (6)
Identification and synthesis of 2,7-diamino-thiazolo[5,4-d]pyrimidine derivatives as TRPV1 antagonists

2009 Bioorganic & Medicinal Chemistry Letters
Show All
- Source
- Cite
- Save
Citations (16)
2-Aryl benzimidazoles featuring alkyl-linked pendant alcohols and amines as inhibitors of checkpoint kinase Chk2.

2007 Bioorganic & Medicinal Chemistry Letters
Show All
- Source
- Cite
- Save
Citations (24)